Progyny

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Progyny and other ETFs, options, and stocks.

About PGNY

Progyny, Inc. is a fertility benefits management company. It provides fertility solutions to employers, managing IUI, in vitro fertilization (IVF), egg freezing, and other fertility treatments. 

CEO
Peter Anevski
CEOPeter Anevski
Employees
856
Employees856
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2008
Founded2008
Employees
856
Employees856

PGNY Key Statistics

Market cap
2.01B
Market cap2.01B
Price-Earnings ratio
32.53
Price-Earnings ratio32.53
Dividend yield
Dividend yield
Average volume
1.61M
Average volume1.61M
High today
$25.72
High today$25.72
Low today
$24.55
Low today$24.55
Open price
$24.59
Open price$24.59
Volume
1.18M
Volume1.18M
52 Week high
$28.75
52 Week high$28.75
52 Week low
$16.10
52 Week low$16.10

Stock Snapshot

Progyny(PGNY) stock is priced at $25.69, giving the company a market capitalization of 2.01B. It carries a P/E multiple of 32.53.

During the trading session on 2026-05-27, Progyny(PGNY) shares reached a daily high of $25.72 and a low of $24.55. At a current price of $25.69, the stock is +4.6% higher than the low and still -0.1% under the high.

Trading activity shows a volume of 1.18M, compared to an average daily volume of 1.61M.

The stock's 52-week range extends from a low of $16.10 to a high of $28.75.

The stock's 52-week range extends from a low of $16.10 to a high of $28.75.

PGNY News

TipRanks 4h
Progyny Shareholders Approve Governance Changes at 2026 Meeting

Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...

Simply Wall St 9h
Progyny Buyback Raises Questions On Capital Returns And Growth Plans

Progyny (NasdaqGS:PGNY) announced a US$200 million share repurchase program approved by its Board. The authorization allows the company to buy back its common...

Progyny Buyback Raises Questions On Capital Returns And Growth Plans
TipRanks 1d
Progyny announces $200M share repurchase program

Progyny (PGNY) announced that its Board of Directors has approved a share repurchase program to repurchase up to $200 million of its common stock. The program w...

Analyst ratings

91%

of 11 ratings
Buy
90.9%
Hold
9.1%
Sell
0%

More PGNY News

Investing.com 1d
Progyny authorizes $200 million share buyback program - Investing.com

...

Progyny authorizes $200 million share buyback program - Investing.com
Nasdaq 1d
Progyny Authorized Up To $200 Mln Buyback

(RTTNews) - Progyny, Inc. (PGNY), a women's health and family building solutions company, Tuesday announced that it has been authorized to repurchase up to $200...

Progyny Authorized Up To $200 Mln Buyback
Simply Wall St 4d
Does Progyny Still Deserve a Premium Narrative After Its Latest Growth Upgrade and Conference Spotlight?

Earlier in May, Progyny, Inc. presented at the Bank of America Global Healthcare Conference 2026 in Las Vegas, featuring CEO Peter Anevski and CFO Mark S. Livin...

Does Progyny Still Deserve a Premium Narrative After Its Latest Growth Upgrade and Conference Spotlight?

People also own

Based on the portfolios of people who own PGNY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.